Canbay A et al. Increasing risk of disease progression and mortality in non-alcoholic fatty liver disease/non-alcoholic statohepatitis patients with advanced liver disease: A German real-world analysis. (Abstract PS-060),Boursier J et al. Increased risk of mortality with liver disease progression in non-alcoholic fatty liver disease/non-alcoholic statohepatitis patients: An analysis of French national hospital care. (Abstract THU-299)
Effectiviteit van online groepsrevalidatie bij long COVID
jun 2024 | Virale infecties